Skip to main content

Table 3 Number and percentage of usable specimens by clinical site

From: Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

 

Site 1

Site 2

Site 3

Site 4

Site 5

Site 6

Total

Sputum visits, n:

16

26

38

30

23

19

152

Usable specimens, n

13

21

34

27

17

14

126

Usable specimens,%

81%

81%

89%

90%

74%

74%

83%

Blood & BAL visits, n:

7

26

28

19

19

18

117

Usable blood specimens, n

6

22

25

19

17

17

106

Usable blood specimens, %

86%

85%

89%

100%

89%

94%

91%

Usable BAL specimens, n

6

21

22

12

15

15

91

Usable BAL specimens, %

86%

81%

76%

63%

79%

83%

78%